Euromonitor International
- Item successfully added to cart!
  
  Your cart is empty
  
  View Cart Check Out

Country Report

Rx/Reimbursement adult incontinence in

Rx/Reimbursement Adult Incontinence in Sweden

Jun 2020

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PRE-COVID-19 PERFORMANCE

Ageing population helps drive continued growth in rx/reimbursement adult incontinence

The growth in rx/reimbursement adult incontinence is, as with retail adult incontinence, stimulated by a growing and ageing population in Sweden. The risk of being affected by incontinence concerns increases considerably the older a person gets, and it is estimated by the Swedish Medical Products Agency that half of the costs for rx/reimbursement adult incontinence products are related to people that are 80 years or older.

Stigma hinders rx/reimbursement adult incontinence growth

In order for Swedish consumers to get access to the rx/reimbursement adult incontinence products provided by the government, they have to go through a certain process. People that experience incontinence problems will have to get in touch with a doctor, nurse or health professional in order to be examined and diagnosed.

Societal acceptance the key to growth

Even though there is still some stigma attached to incontinence products, it is gradually disappearing. In a report from Västmanlands län, a county in Sweden, the number of orders of rx/reimbursement incontinence products in 2018 grew by 17.

2020 AND BEYOND

COVID-19 impact

Sales of rx/reimbursement adult incontinence are expected to grow by 3% at constant 2019 prices in 2020. This is the same forecast performance that appeared in our 2020 edition published in February 2020 (pre-COVID-19).

Recovery and opportunities

If COVID-19 results in a prolonged or very harsh economic downturn in Sweden, this could help rx/reimbursement adult incontinence, given the category’s products are available free through prescription. However, the short- and medium-term forecast performance currently looks unchanged for these products.

Files are delivered directly into your account within a few minutes of purchase.

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

SAMPLES

FAQS ABOUT SAMPLES

DELIVERY

Files are delivered directly into your account within a few minutes of purchase.

OVERVIEW

Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Sweden with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Rx/Reimbursement adult incontinence industry in Sweden, our research will save you time and money while empowering you to make informed, profitable decisions.

The Rx/Reimbursement adult incontinence in Sweden market research report includes:

Analysis of key supply-side and demand trends
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Rx/Reimbursement adult incontinence in Sweden?
What are the major brands in Sweden?
What are the most important channels for Rx/Reimbursement adult incontinence products?
How do light incontinence products perform compared to moderate/heavy incontinence products?

WHY BUY THIS REPORT?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our

Tissue and Hygiene market research database

Want to find out more about this report?

Request more information

Rx/Reimbursement Adult Incontinence in Sweden - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Ageing population helps drive continued growth in rx/reimbursement adult incontinence

Stigma hinders rx/reimbursement adult incontinence growth

Societal acceptance the key to growth

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Table 1 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2014-2019
Table 2 Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2014-2019
Table 3 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP 2019-2024
Table 4 Forecast Sales of Rx/Reimbursement Adult Incontinence: Total Value MSP Growth 2019-2024

Tissue and Hygiene in Sweden - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Consumers increasingly looking for sustainable or green products

Private label holds the biggest share of retail sales; e-commerce continues to grow

Retail sales will rebound from the COVID-19 hit, AFH will struggle to offset the 2020 damage to its sales

Chart 1 Tissue and Hygiene Value Sales Growth Scenarios: 2016-2024
Chart 2 Tissue and Hygiene Impact of Soft Drivers on Value Sales: 2016-2024

MARKET INDICATORS

Table 5 Birth Rates 2014-2019
Table 6 Infant Population 2014-2019
Table 7 Female Population by Age 2014-2019
Table 8 Total Population by Age 2014-2019
Table 9 Households 2014-2019
Table 10 Forecast Infant Population 2019-2024
Table 11 Forecast Female Population by Age 2019-2024
Table 12 Forecast Total Population by Age 2019-2024
Table 13 Forecast Households 2019-2024

MARKET DATA

Table 14 Retail Sales of Tissue and Hygiene by Category: Value 2014-2019
Table 15 Retail Sales of Tissue and Hygiene by Category: % Value Growth 2014-2019
Table 16 NBO Company Shares of Retail Tissue and Hygiene: % Value 2015-2019
Table 17 LBN Brand Shares of Retail Tissue and Hygiene: % Value 2016-2019
Table 18 Penetration of Private Label in Retail Tissue and Hygiene by Category: % Value 2014-2019
Table 19 Distribution of Retail Tissue and Hygiene by Format: % Value 2014-2019
Table 20 Distribution of Retail Tissue and Hygiene by Format and Category: % Value 2019
Table 21 Forecast Retail Sales of Tissue and Hygiene by Category: Value 2019-2024
Table 22 Forecast Retail Sales of Tissue and Hygiene by Category: % Value Growth 2019-2024

Megatrends

Country Report

Rx/Reimbursement Adult Incontinence in Sweden

New Report Guarantee

Executive Summary

New Report Guarantee

PRE-COVID-19 PERFORMANCE

Ageing population helps drive continued growth in rx/reimbursement adult incontinence

Stigma hinders rx/reimbursement adult incontinence growth

Societal acceptance the key to growth

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

Overview

Why buy this report?

SAMPLES

DELIVERY

OVERVIEW

WHY BUY THIS REPORT?

Want to find out more about this report?

Table of Contents

Rx/Reimbursement Adult Incontinence in Sweden - Category analysis

HEADLINES

PRE-COVID-19 PERFORMANCE

Ageing population helps drive continued growth in rx/reimbursement adult incontinence

Stigma hinders rx/reimbursement adult incontinence growth

Societal acceptance the key to growth

2020 AND BEYOND

COVID-19 impact

Recovery and opportunities

CATEGORY DATA

Tissue and Hygiene in Sweden - Industry Overview

EXECUTIVE SUMMARY

COVID-19 impact on tissue and hygiene

COVID-19 country impact

Consumers increasingly looking for sustainable or green products

Private label holds the biggest share of retail sales; e-commerce continues to grow

Retail sales will rebound from the COVID-19 hit, AFH will struggle to offset the 2020 damage to its sales

MARKET INDICATORS

MARKET DATA

GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Recently Viewed

Complete Catalogue

Country Reports